报价延迟最少15分钟:2026/04/03 17:16 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
108.49 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
2.52/3.17
|
|
企业价值
2.66B
|
| 资产负债 |
|
每股账面净值
17.28
|
| 现金流量 |
|
现金流量率
0.03
|
| 损益表 |
|
收益
249.60M
|
|
每股收益
8.15
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded productsused in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas. |
